首页> 外文期刊>Science >Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
【24h】

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

机译:H3K27M胶质瘤的发展和致癌程序,通过单细胞RNA-seq进行解剖

获取原文
获取原文并翻译 | 示例
       

摘要

Gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) arise primarily in the midline of the central nervous system of young children, suggesting a cooperation between genetics and cellular context in tumorigenesis. Although the genetics of H3K27M-glioma are well characterized, their cellular architecture remains uncharted. We performed single-cell RNA sequencing in 3321 cells from six primary H3K27M-glioma and matched models. We found that H3K27M-glioma primarily contain cells that resemble oligodendrocyte precursor cells (OPC-like), whereas more differentiated malignant cells are a minority. OPC-like cells exhibit greater proliferation and tumor-propagating potential than their more differentiated counterparts and are at least in part sustained by PDGFRA signaling. Our study characterizes oncogenic and developmental programs in H3K27M-glioma at single-cell resolution and across genetic subclones, suggesting potential therapeutic targets in this disease.
机译:具有组蛋白H3赖氨酸27-甲硫氨酸突变(H3K27M-神经胶质瘤)的胶质瘤主要出现在幼儿中枢神经系统的中线,这提示遗传学和细胞背景在肿瘤发生中具有协同作用。尽管H3K27M神经胶质瘤的遗传学已得到很好的表征,但它们的细胞结构仍然未知。我们对来自六个原发性H3K27M神经胶质瘤和匹配模型的3321个细胞进行了单细胞RNA测序。我们发现H3K27M胶质瘤主要包含类似于少突胶质前体细胞(OPC样)的细胞,而分化程度更高的恶性细胞则占少数。 OPC样细胞比其分化程度更高的细胞具有更大的增殖能力和肿瘤扩散潜力,并且至少部分由PDGFRA信号传导维持。我们的研究以单细胞分辨率和跨基因亚克隆的形式表征H3K27M神经胶质瘤的致癌和发育程序,提示该疾病的潜在治疗靶点。

著录项

  • 来源
    《Science》 |2018年第6386期|331-335|共5页
  • 作者单位

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Broad Inst Harvard & Massachussetts Inst Technol, Klarman Cell Observ, Cambridge, MA 02142 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Med Univ Vienna, St Anna Kinderspital, CCRI, Vienna, Austria;

    Boston Childrens Hosp, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Med Univ Vienna, Inst Neurol, Vienna, Austria;

    Broad Inst Harvard & MIT, Cambridge, MA 02142 USA;

    Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Dana Farber Canc Inst, Lurie Family Imaging Ctr, Ctr Biomed Imaging Oncol, Boston, MA 02215 USA;

    Dana Farber Canc Inst, Lurie Family Imaging Ctr, Ctr Biomed Imaging Oncol, Boston, MA 02215 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA;

    Med Univ Vienna, Dept Neurosurg, Vienna, Austria;

    Med Univ Vienna, Dept Neurosurg, Vienna, Austria;

    Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA;

    Hosp St Joan Deu, Dev Tumor Biol Lab, Barcelona 08950, Spain;

    Hosp St Joan Deu, Dev Tumor Biol Lab, Barcelona 08950, Spain;

    Hosp St Joan Deu, Dev Tumor Biol Lab, Barcelona 08950, Spain;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria;

    Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia;

    Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Hematol Oncol,Dept Neurol, Boston, MA USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA;

    Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA;

    Harvard Med Sch, Boston, MA 02114 USA;

    Med Univ Vienna, St Anna Kinderspital, CCRI, Vienna, Austria;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Broad Inst Harvard & Massachussetts Inst Technol, Klarman Cell Observ, Cambridge, MA 02142 USA;

    Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA;

    Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria;

    Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA;

    Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA;

    Broad Inst Harvard & Massachussetts Inst Technol, Klarman Cell Observ, Cambridge, MA 02142 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:08

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号